Noonan syndrome management and follow-up: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:


* The second most common cardiac manifestation of Noonan syndrome is [[hypertrophic cardiomyopathy]]. Management is usually similar to most patients with HCM and includes [[beta-blockers]] and surgical [[myomectomy]] in certain cases with significant outflow obstruction. <ref name="pmid20876176">{{cite journal| author=Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME et al.| title=Noonan syndrome: clinical features, diagnosis, and management guidelines. | journal=Pediatrics | year= 2010 | volume= 126 | issue= 4 | pages= 746-59 | pmid=20876176 | doi=10.1542/peds.2009-3207 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20876176 }} </ref>
* The second most common cardiac manifestation of Noonan syndrome is [[hypertrophic cardiomyopathy]]. Management is usually similar to most patients with HCM and includes [[beta-blockers]] and surgical [[myomectomy]] in certain cases with significant outflow obstruction. <ref name="pmid20876176">{{cite journal| author=Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME et al.| title=Noonan syndrome: clinical features, diagnosis, and management guidelines. | journal=Pediatrics | year= 2010 | volume= 126 | issue= 4 | pages= 746-59 | pmid=20876176 | doi=10.1542/peds.2009-3207 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20876176 }} </ref>


===Endocrine and Developmental===
===Endocrine and Developmental===

Revision as of 23:46, 14 November 2013

Noonan syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Noonan syndrome from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

ECG Findings

Other Diagnostic Studies

Treatment

Management & Follow-up

Genetic Counseling

Case Studies

Case #1

Noonan syndrome management and follow-up On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Noonan syndrome management and follow-up

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Noonan syndrome management and follow-up

CDC on Noonan syndrome management and follow-up

Noonan syndrome management and follow-up in the news

Blogs on Noonan syndrome management and follow-up

Directions to Hospitals Treating Noonan syndrome

Risk calculators and risk factors for Noonan syndrome management and follow-up

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Serge Korjian

Overview

Management and Follow-up

A mutlidisciplinary team is often needed in the management of Noonan syndrome. A system-based approach is usually adopted and recommendations are based on the severity of disease manifestations.

Cardiovascular

  • Patients with Noonan syndrome require lifetime cardiac follow-up. After initial evaluation including a focused cardiac physical exam, echocardiography, and electrocardiography, follow up is based on work-up findings. If initial work-up is unremarkable, a follow up is recommended every 5 years. [1][2]
  • The most common cardiac finding is pulmonary valve stenosis. If mild, only periodic follow-up is recommended. If clinically significant, pulmonary balloon valvuloplasty is recommended in the absence of significant valve dysplasia. With significantly dysplastic valves a pulmonary valvectomy or pulmonary valve homograft during childhood is the first line management. [3]

Endocrine and Developmental

Renal and Genitourinary

Hematology and Oncology

Neurologic and Behavioral

Gastrointestinal

Lymphatic

References

  1. Roberts AE, Allanson JE, Tartaglia M, Gelb BD (2013). "Noonan syndrome". Lancet. 381 (9863): 333–42. doi:10.1016/S0140-6736(12)61023-X. PMID 23312968.
  2. van der Burgt I (2007). "Noonan syndrome". Orphanet J Rare Dis. 2: 4. doi:10.1186/1750-1172-2-4. PMC 1781428. PMID 17222357.
  3. 3.0 3.1 Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME; et al. (2010). "Noonan syndrome: clinical features, diagnosis, and management guidelines". Pediatrics. 126 (4): 746–59. doi:10.1542/peds.2009-3207. PMID 20876176.

Template:Phakomatoses and other congenital malformations not elsewhere classified


Template:WikiDoc Sources